Companies / Kuwait
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Jordan Continues To Develop As A Drug Manufacturing Base
January 2007 | Company Finance AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
According to recently released data, the Jordanian drug industry exported products worth JOD198.6mn (US$280mn) in 2005, which is directly in line with BMI estimates. However, BMI believes that the Jordanian government's forecast that the sector will more than triple by 2010 to reach US$1bn is overly optimistic. BMI expects the market to reach only US$450mn by 2010, due to strong global price pressure on generic medicines. Adnan Badwan, the general director of local drugmaker JPM reflects this view, claiming that the government prediction is not 'feasible' primarily owing to a lack of capital investment in the